Mutations in the BRWD3 Gene Cause X-Linked Mental Retardation Associated with Macrocephaly  by Field, Michael et al.
www.ajhg.org The American Journal of Human Genetics Volume 81 August 2007 367
REPORT
Mutations in the BRWD3 Gene Cause X-Linked Mental
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In the course of systematic screening of the X-chromosome coding sequences in 250 families with nonsyndromic X-
linked mental retardation (XLMR), two families were identiﬁed with truncating mutations in BRWD3, a gene encoding
a bromodomain andWD-repeat domain–containing protein. In both families, themutation segregateswith thephenotype
in affected males. Affected males have macrocephaly with a prominent forehead, large cupped ears, andmild-to-moderate
intellectual disability. No truncating variants were found in 520 control X chromosomes. BRWD3 is therefore a new gene
implicated in the etiology of XLMR associated with macrocephaly andmay cause disease by altering intracellular signaling
pathways affecting cellular proliferation.
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For many years, it has been recognized that the presence
of macrocephaly (a head circumference [HC] 12 SD above
the mean) or microcephaly is more common in the men-
tally retarded population. Mentally retarded individuals
are at least twice as likely to have macrocephaly than are
their intellectually normal peers.1 Macrocephaly is also
seen in ∼20% of autistic individuals.2,3 The neuropatho-
logical basis of macrocephaly is not well understood, but
the presence of this feature can be helpful in restricting
the differential diagnosis in a male with mental retar-
dation. However, macrocephaly is common in a number
of well-known X-linked mental retardation (XLMR) syn-
dromes—such as fragile X syndrome, FG syndrome, and
Lujan syndrome—and it is both clinically and genetically
heterogeneous and, as an isolated feature, is a poor diag-
nostic discriminator. Families have been reported with ap-
parently rare or unique XLMR macrocephaly syndromes.
These include three families with macrocephaly, facial
coarsening, obesity, andmacro-orchidism.4–6 A further fam-
ily with macrocephaly and macro-orchidism without fa-
cial coarsening has shown linkage to Xq12-q21.7 In this
last family, the presence of macrocephaly was also ob-
served in a number of intellectually normal males. An-
other family with XLMR and macrocephaly in both hemi-
zygousmales and heterozygous females has shown linkage
to Xp11-Xq12.8 Relative macrocephaly and short stature
are also features of MRX2, which has been mapped to
Xq22.9,10
Here, we describe two families with mental retardation
andmacrocephaly and an X-linked pattern of inheritance.
In each family, we have identiﬁed a different protein-trun-
cating mutation in the BRWD3 gene (MIM 300553), lo-
cated at Xq21.1. A third family with mild intellectual han-
dicap but without macrocephaly had a missense sequence
variant in the same gene. No sequence variants were de-
tected in the XLMR-macrocephaly–affected families de-
scribed by Johnson et al.7 and Turner et al.8
Our study cohort contained 250 families in which two
or more males were affected with mental retardation. A
sample from each family was selected and is being sub-
jected to systematic sequence analysis of the coding exons
and splice junctions of 676 Vega annotated genes (Vega
Genome Browser) on the X chromosome by bidirectional,
PCR-based direct sequencing.11,12 All samples had been pre-
screened and were excluded from further study if a kar-
yotype abnormality was present or a mutation was iden-
tiﬁed in FMR1 or in one of the other 61 X-chromosome
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Figure 1. Family pedigrees. A blackened symbol indicates the presence of mental retardation; a horizontal bar above a symbol indicates
that DNA was collected and analyzed.
genes that are known to be associated with syndromic or
nonsyndromic mental retardation.
Family 322 included a nephew and an uncle with mild-
to-moderate mental retardation and an aunt with mild
cognitive difﬁculties during early childhood (ﬁg. 1). The
pregnancy of proband III-6 was complicated by vaginal
bleeding from 28 wk. He was delivered by lower-segment
cesarean delivery because of placenta previa at 34 wk ges-
tation, weighing 2.3 kg (50th–75th percentile) and with
an HC of 33 cm (75th percentile). He had a left-sided
unilateral cleft lip and disruption of the alveolar ridge. An
unaffected paternal uncle was born with a cleft lip and
palate. The proband’s right testis was undescended and
was brought down by orchiopexy at age 13 mo. He sat
unsupported at age 10 mo, ﬁrst said “Dad” at age 13 mo,
walked alone at age 16 mo, and was toilet trained at age
3 years and 5 mo. Muscular hypotonia was noted in early
life. He had limited functional language until age 8 years,
despite having normal hearing for speech. He was affec-
tionate but was shy and reserved with strangers. He at-
www.ajhg.org The American Journal of Human Genetics Volume 81 August 2007 369
Figure 2. Clinical photography of families 322 and 336. a and b, Subject III-6 of family 322, aged 17 years. c, Subject II-11 of family
322. d and e, Brothers from family 336, aged 13 and 9 years. Note similar facial features, including prominent forehead; large, prominent
ears; and pointed chin.
tended a remedial class in mainstream primary and sec-
ondary school. At age 13 years, his combined IQ was 65
on the WISC (Wechsler Intelligence Scale for Children),
with a verbal score in the 0.4th percentile, and his per-
formance score was in the 37th percentile, with relative
strengths in visual and spatial tests. He is now able to read
and write simple material, but he has limited numeracy
skills. He is independent for tasks of daily living. A normal
echocardiogram was obtained after a murmur was heard
at age 8 years. A CT scan of his head at age 17 years showed
megalencephaly without hydrocephalus or other struc-
tural anomaly.
The height, weight, and HC of proband III-6 were con-
sistently 197th percentile. When assessed at age 17 years,
his height was 190 cm (k97th percentile), weight was 88
kg (90th percentile), and HC was 62 cm (k98th percen-
tile). His facial features (ﬁg. 2a and 2b) included a long
face, pointed chin, and large, prominent ears. He hadmild
central obesity. His body proportions were normal, with
an arm span of 192 cm. His hands and feet were large;
hand length was 20.5 cm (97th percentile), middle-ﬁnger
length was 8.6 cm (90th percentile), and the ﬁngers were
tapered. He had marked pes planus with shortened 4th
and 5th toes. He had minimal facial or axillary hair. Gen-
ital pubertal development was at Tanner stage IV.
The affected uncle, II-11, of the proband (III-6) had a
normal birth weight but grew rapidly in terms of height
and weight during his teenage years. At age 38 years, he
lives alone in a ﬂat and receives a disability pension. His
sister looks after his ﬁnancial affairs. His height is 187 cm
(90th percentile), weight is 73 kg (60th percentile), and
HC is 59 cm (198th percentile). He has frontal bossing;
large, prominent ears; and a pointed chin (ﬁg. 2c). His
build is thin, with a midthoracic kyphosis and minimal
pectus excavatum.
The proband’s mother (II-7) is 165 cm tall (50th per-
centile) and has an HC of 56.5 cm (60th percentile). She
completed formal education until age 16 years. She has
no distinguishing morphological features.
In family 322, a mutation of the highly conserved 1
position of the 5′ donor splice site of intron 29 of the
BRWD3 gene, c.33251GrT (GenBank accession num-
ber NM_153252), was identiﬁed. The affected individuals
II-11 and III-6 carry this mutation, and individual II-7
was identiﬁed as being heterozygous for the mutation.
The mutation was not identiﬁed in an intellectually nor-
mal male cousin, III-3. Analysis of cDNA isolated from
a lymphoblastoid cell line derived from III-6 demon-
strates that this mutation leads to complete skipping of
exon 29 and the introduction of a premature stop codon,
p.W1089CfsX4 (GenBank accession numberNP_694984)
(ﬁg. 3). The c.33251GrT mutation changes the 5′ do-
nor splice-site strength from 73.2% to 54.9% (ﬁg. 3). X-
inactivation studies of three carrier females—II-1, II-7,
and II-10—showed high-to-moderate skewing, with val-
ues of 96:4, 100:0, and 86:14, respectively. In all three
carriers, it is the chromosome carrying the BRWD3
c.33251GrT mutation that is preferentially inactivated
(data not shown).
Family 336 was referred to clinical geneticists for in-
vestigation of their intellectual disability. The family in-
cludes two affected half-brothers, who share the same
mother (ﬁg. 1). Both boys were removed from the care of
the mother because of neglect and have been adopted.
There has been no contact with the extended biological
family. The boys’ mother is reported to have an intellec-
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Figure 3. Mutation analysis of BRDW3. a, DNA-sequence chromatograms showing the mutations in BRWD3 in genomic DNA from families
322, 336, and 328. The position of the mutation is indicated with an arrow. Control and affected-male sequence analyses are shown.
b, RT-PCR analysis of the BRWD3 gene on lymphocyte RNA of proband III-6 from family 322 (blackened square) and a control individual
(unblackened square). Primer sequences and conditions are available on request. M indicates pUC19/HpaII size marker, and plus ()
and minus () signs indicate the presence or absence of reverse transcriptase, respectively. c, Schematic diagrams showing BRWD3
splicing in a control individual (unblackened square) and patient III-6 from family 322 (blackened square) with the c.33251GrT
mutation. The mutation results in aberrant splicing—that is, exclusion of exon 29 (dark gray) from the mature BRWD3 mRNA. The
percentages given show exon 29 5′ splice-site consensus strength with and without the c.33251GrT mutation. In panel d, the sequence
resulting from the splice-site mutation is illustrated in red, and the control cDNA sequence is in black. e, Sequence chromatogram of
the BRWD3 RT-PCR product of patient III-6, showing the absence of exon 29 from the mRNA.
tual disability. Her HC was recorded as 57 cm (97th
percentile).
The elder boy was born at 38 wk gestation after a labor
with prolonged fetal bradycardia, resulting in a cesarean
delivery. He weighed 2.72 kg (9th–25th percentile), and
his HC was 37 cm (98th percentile). During infancy, his
height was in the 2nd percentile, and his HC was in the
97th percentile. He crawled at age 19 mo and walked at
age 2 years. He went into foster care at age 4 years. At age
6 years, he could walk but not run and was not toilet
trained. He had few words and limited speech. He had an
undescended testis. He is being educated in a support class
and has a moderate learning disability. He is able to read
and write and has improved language skills. He has no
sense of danger. He is clumsy, falls frequently, has difﬁ-
culties with ﬁne-motor control, and is prone to temper
tantrums. At age 13 years, his height was 137 cm (0.4th–
2nd percentile), his weight was 30 kg (0.4th–2nd per-
centile), and his HC was 57 cm (97th percentile). His face
is long with a broad, prominent forehead and a small
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pointed chin (ﬁg. 2d and 2e). His ears are cupped and
posteriorly rotated.
His half-brother was born at 38 wk gestation by elective
cesarean delivery andweighed 3.680 kg (175th percentile),
with an HC of 37 cm (98th percentile). He was placed in
emergency foster care at age 5 mo and was subsequently
adopted with his brother. At age 7 mo, developmental
delay was noted. He crawled at age 14 mo, and he walked
at age 18 mo. He was noted to have mild muscular hy-
potonia. At age 22 mo, his speech was assessed at a 9-
mo level, and global development was assessed at a 12-
mo level. A Grifﬁths assessment at age 39 mo showed that
locomotor skills were age appropriate, but language and
hand-eye coordination were at the 29-mo level. Results of
a hearing assessment during early childhoodwere normal.
At age 9 years, he attended a regular schoolwith additional
assistance and has a mild learning disability. He has no
sense of danger and has behavioral problems, with fre-
quent temper tantrums and head banging. At age 9 years,
his height was 134 cm (50th percentile), weight was 30
kg (50th percentile), and HCwas 57 cm (197th percentile).
He has macrocephaly, frontal bossing, a pointed chin, and
prominent ears with cupped helices.
A BRWD3 frameshift mutation, c.946-947insA, which
leads to a predicted truncated protein p.R316KfsX21, was
identiﬁed in both affected males from this family (see ﬁg.
3). The biologicalmother was not available for assessment,
and no further follow-up has been possible, because of the
children’s adoption proceedings.
Family 328 was reported elsewhere by Gedeon et al. as
family E.13 The family includes three brothers, a cousin,
and an uncle, all with borderline-to-mild mental retar-
dation (ﬁg. 1). A developmental assessment of one of the
males during early childhood identiﬁed speech delay as
more marked than delay in other domains. None of the
affected males had macrocephaly or tall stature in child-
hood. They were noted to have large, prominent ears (ear
length 12 SD) and, in retrospect, a triangular face and
pointed chin. The family has been contacted but, at pre-
sent, has declined clinical follow-up.
Amissense BRWD3 variant, c.4786ArG (p.K1596E),was
identiﬁed in all affected males of family 328 (see ﬁg. 3).
This variant segregates with the XLMR phenotype in the
individuals assessed. However, the location of BRWD3 dis-
agrees with the suggestive ( ) linkage intervalLODp 1.8
(DXS207–DXS426) obtained for this family and reported
elsewhere.13 This apparent discrepancy and likely incor-
rect localization in the work of Gedeon et al.13 was due to
a wrong initial diagnosis of the condition of one of the
boys (III-6) (ﬁg. 1). At the time of the linkage mapping of
this family, the boy was aged only 1 year andwas classiﬁed
as “unaffected.” More than 10 years later, this individual
was reassessed and received the diagnosis of mild mental
retardation. The two-point LOD score (5.2) for pedigree
328 was recalculated with correct clinical assignments,
and the BRWD3 c.4786ArG/ genotypes were identiﬁed.
A maximum LOD score of 2.11 at BRWD3 ( ) wasvp 0
obtained. X-linked recessive inheritance and a disease fre-
quency of 1:10,000 was assumed, with penetrance set at
1.00.
SIFT and Polyphen analysis of the sequence variant
K1596E predicts this change to be deleterious to the func-
tion of the protein. Analysis of conservation of the protein
sequence across species shows that the residue K1596 is
conserved across mammalian species but is not conserved
in Xenopus, Drosophila, or Caenorhabditis elegans (see ﬁg.
4) (BLAST; ClustalW). Analysis of X inactivation showed
random or slightly skewed inactivation of the chro-
mosome carrying the c.4786ArG (p.K1596E) mutation.
Whereas subject I-1 showed almost random (65:35) in-
activation on the basis of the evaluation of the androgen
receptor gene (AR), subjects II-1 and II-4 showedmodestly
skewed X-chromosome inactivation, at 80:20 and 84:16,
respectively.
In this report, we have identiﬁed 2 of 250 probands from
XLMR-affected families with truncating mutations in the
BRWD3 gene. Mutations in this gene therefore account
for ∼1% of XLMR. Neither of the identiﬁed truncatingmu-
tations was present in 520 control X chromosomes. A single
synonymous sequence variant (c.5100TrC [pG1700G])was
identiﬁed in the remaining patient samples. This variant
is unlikely to be pathogenic, particularly since the carrier
has a disease-causing mutation in CUL4B.11 Interestingly,
no other variants were identiﬁed in 520 control X chro-
mosomes after sequencing all coding exons of BRWD3.
The role of the c.4786ArG missense variant in family 328
is unclear. Although it may be responsible for XLMR in
this family, the absence of shared phenotypic featureswith
families 322 and 336 may equally indicate that it is a rare,
innocuous sequence polymorphism. However, the milder
clinical phenotype and absence ofmacrocephaly in family
328, compared with the two families with truncating mu-
tations, may reﬂect the milder pathogenicity of this mu-
tation or may reﬂect the common variations in phenotype
typically described in XLMR-affected families published
elsewhere.11
Both of the families with truncatingmutationshadmac-
rocephaly noted in infancy, prominent ears, and mild-to-
moderate developmental delay. A disproportionate delay
in language skills has been documented in both families.
The one congenital malformation seen in these families
was a cleft lip in the proband of family 322. We think this
is likely to relate to the paternal history of oral clefting
rather than to the mutation in BRWD3.
The BRWD3 gene was ﬁrst identiﬁed when the break-
points of an X-autosome translocation t(X;11) in a B-cell
chronic lymphocytic leukemia (B-CLL) cell line were
cloned.14 In the leukemic cells, the translocationdisrupted
the production of the BRWD3 transcript. BRWD3 maps to
Xq21.1 (79.81–79.95 Mb). The gene is ubiquitously ex-
pressed, including in the brain and during embryonic de-
velopment. BRWD3 encodes a protein containing eight
WD40 domains and two bromodomains. BRWD3 shares
homology with at least two other human genes: ABCG2
Figure 4. Protein alignments of vertebrate BRWD3 orthologues. Only partial sequences, corresponding to the human BRWD3 protein p.1551–1611, are shown. The lysine (K) residue
at position 1596 is conserved, as indicated by an arrow. The amino acid residues that do not match the consensus sequence are highlighted with black boxes.
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Figure 5. Schematic representation of the four predicted major
isoforms of BRWD3. The amino terminus is to the left of the image.
The WD40-repeat region is indicated by boxes marked with hori-
zontal lines, and the bromodomains are indicated by the boxes
marked with diagonal lines. The positions of the mutations relative
to the translated products are indicated by arrows.
(MIM 603756) and WDR11 (MIM 606417) (also called
“BRWD1” and “BRWD2,” respectively). Thirteen splice
variants have been identiﬁed.14 From these splice variants,
four possible translated products that contain the bromo-
domains are possible, calculated to produce polypeptides
of 1,802, 1,631, 1,472, and 1,398 aa (ﬁg. 5). It is interesting
to note that the c.946-947insAmutation occurs before the
translation start site of the two shorter protein isoforms.
In the two longer protein isoforms, the c.946-947insA
leads to a frameshift and an early truncation of the protein
within the WD40-repeat region. The c.33251GrT mu-
tation also causes a frameshift that results in truncation
of the protein before the ﬁrst bromodomain in all of the
protein isoforms. Given the similarities of the phenotype
between families 322 and 336, it seems likely that the two
shorter protein isoforms do not play a signiﬁcant role in
the pathology of this disorder.
Data about Drosophila (Berkeley Drosophila Genome
Project) indicate that the putative BRWD3 orthologue acts
as a positive regulator of the JAK/STAT–signaling path-
way.15 Up-regulation of the JAK/STAT pathway is associ-
ated with hemocyte proliferation and melanoma progres-
sion in the ﬂy. Down-regulation of BRWD3 gene expres-
sion leads to reduced JAK/STAT–signaling activity and re-
duces tumor progression in the presence of a second gain-
of-function mutation within the pathway.15 InDrosophila,
the JAK/STAT pathway is involved in intracellular signal-
ing, growth, and embryogenic development. The pathway
is conserved in vertebrates.16 Inherited mutations in genes
in the JAK/STAT pathway have not yet been implicated in
human disease, although dysregulation of the pathway
through somatic-activating mutations has been reported
in human myeloproliferative and other hematological
disorders.17
A putative mode of action of BRWD3 may be surmised
from its structure. Bromodomains are typically present in
chromatin-associated proteins, many of which have a
chromatin-modifying function.18 The bromodomain re-
gion in the P/CAF protein has been shown to be crucial
for chromatin binding via lysine-acetylated peptides as-
sociated with major acetylation sites on histones H3 and
H4.19 Removal of the bromodomain in chromatin-regu-
latory proteins such as Swi/Snf2 and the SAGA complex
removes their ability to remain anchored to chromatin.20,21
RNA-interference studies in Drosophila indicate that the
BRWD3 gene functions downstream in the JAK/STATpath-
way, which would be compatible with the protein having
a chromatin-binding function and hence having an effect
on DNA transcription.15 The presence of WD40 domains
may facilitate the formation of protein complexes.14
In summary, we have identiﬁed truncating mutations
in the BRWD3 gene in two families with a constellation
of features including macrocephaly; mild-to-moderate de-
lay, with speciﬁc weaknesses in early language develop-
ment associated with frontal bossing; and prominent ears.
The identiﬁedmutations would produce a loss-of-function
effect on the pathway. Loss of BRWD3 function seems
likely to lead to loss of normal developmental signaling
and implicates the JAK/STAT pathway in the etiology of
XLMR. Screening for mutations in this gene may be ap-
propriate for individuals with macrocephaly and a family
history compatible with XLMR.
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